当前位置： SCI文献检索 > CHEST期刊下所有文献 > Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.

Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.

Abstract：

BACKGROUND:Patients with malignant pleural effusion (MPE) have limited prognoses. They require long-lasting symptom relief with minimal hospitalization. Indwelling pleural catheters (IPCs) and talc pleurodesis are approved treatments for MPE. Establishing the implications of IPC and talc pleurodesis on subsequent hospital stay will influence patient choice of treatment. Therefore, our objective was to compare patients with MPE treated with IPC vs pleurodesis in terms of hospital bed days (from procedure to death or end of follow-up) and safety. METHODS:In this prospective, 12-month, multicenter study, patients with MPE were treated with IPC or talc pleurodesis, based on patient choice. Key end points were hospital bed days from procedure to death (total and effusion-related). Complications, including infection and protein depletion, were monitored longitudinally. RESULTS:One hundred sixty patients with MPE were recruited, and 65 required definitive fluid control; 34 chose IPCs and 31 pleurodesis. Total hospital bed days (from any causes) were significantly fewer in patients with IPCs (median, 6.5 days; interquartile range [IQR] = 3.75-13.0 vs pleurodesis, mean, 18.0; IQR, 8.0-26.0; P = .002). Effusion-related hospital bed days were significantly fewer with IPCs (median, 3.0 days; IQR, 1.8-8.3 vs pleurodesis, median, 10.0 days; IQR, 6.0-18.0; P < .001). Patients with IPCs spent significantly fewer of their remaining days of life in hospital (8.0% vs 11.2%, P < .001, χ(2) = 28.25). Fewer patients with IPCs required further pleural procedures (13.5% vs 32.3% in pleurodesis group). There was no difference in rates of pleural infection (P = .68) and protein (P = .65) or albumin loss (P = .22). More patients treated with IPC reported immediate (within 7 days) improvements in quality of life and dyspnea. CONCLUSIONS:Patients treated with IPCs required significantly fewer days in hospital and fewer additional pleural procedures than those who received pleurodesis. Safety profiles and symptom control were comparable.

journal_name

Chest

journal_title

Chest

authors

Fysh ETH,Waterer GW,Kendall PA,Bremner PR,Dina S,Geelhoed E,McCarney K,Morey S,Millward M,Musk AWB,Lee YCG

doi

10.1378/chest.11-2657

subject

Has Abstract

pub_date

2012-08-01 00:00:00

pages

394-400

issue

eissn

0012-3692

issn

1931-3543

pii

S0012-3692(12)60452-8

journal_volume

142

pub_type

杂志文章,多中心研究

在线工具

Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.